Trial Profile
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study (PART 2)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jun 2019
Price :
$35
*
At a glance
- Drugs Mosapride (Primary)
- Indications Dyspepsia
- Focus Registrational; Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 25 Jun 2019 Status changed from recruiting to completed.
- 14 Jun 2017 New trial record